|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Lipoic Acid on Ischemia/Reperfusion-Induced Renal Dysfunction in Rats
1 Chonnam National University Medical School, Department of Internal Medicine, Gwangju, Korea, Republic of
2 Chonnam National University Medical School, Department of Physiology, Gwangju, Korea, Republic of
3 University of Aarhus, The Water and Salt Research Center, Denmark
4 Chonbuk National University Medical School, Department of Physiology, Jeonju, Korea, Republic of
* To whom correspondence should be addressed. E-mail: skimw{at}chonnam.ac.kr.
We investigated whether
-lipoic Acid (
-LA), an antioxidant, attenuates the ischemia/reperfusion (I/R)-induced dysregulation of these transporters. Male Sprague-Dawley rats were clamped of both renal pedicles for 40 minutes.
-LA (80 mg/kg) was administered intraperitoneally before and immediately after inducing the ischemia. After 2 days, the expression of aquaporins (AQPs), sodium transporters and nitric oxide synthases (NOS) was determined in the kidney by immunoblotting and immunohistochemistry. The expression of endothelin-1 (ET-1) mRNA was determined by real-time polymerase chain reaction. Activities of adenylyl cyclase and guanylyl cyclase were measured by stimulated generation of cAMP and cGMP, respectively. The expression of AQP1-3 as well as that of
-1 subunit of Na,K-ATPase, NHE3, NKCC2 and NCC was markedly decreased in response to I/R. The expression of type VI adenylyl cyclase was decreased in I/R-injury rats, which was counteracted by the treatment of
-LA. AVP-stimulated cAMP generation was blunted in I/R rats, which was then ameliorated by
-LA treatment.
-LA treatment attenuated the downregulation of AQPs and sodium transporters. The expression of endothelial NOS was decreased in I/R rats, which was prevented by
-LA. The cGMP generation in response to sodium nitroprusside was blunted in I/R rats, which was also significantly prevented by
-LA. The mRNA expression of ET-1 was increased, which was recovered to the control level by
-LA treatment. In conclusion,
-LA treatment prevents I/R-induced dysregulation of AQPs and sodium transporters in the kidney, possibly through preserving normal activities of local AVP/cAMP, NO/cGMP and ET systems.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |